Drug Abuse Testing Market: By Technology (Immunoassay, On-site Testing, Mass Spectrometry and Others), By Sample Type (Urine, Saliva, Blood, Hair and Others) and Geography     

Purchase Option

$ 4400
$ 6660
$ 8900

Drug Abuse Testing (DAT) Market size is valued at USD 2,507.4 million in 2023 and is expected to reach USD 3,307.3 million by 2029, at a CAGR of 3.9% from 2024-2030. The workforce drug testing and drug abuse cases mainly drive the drug abuse testing market. The growth of the drug abuse testing (DAT) market is attributed to the increase in usage of alcohol, cannabinoids, cocaine, amphetamines, opiates, and other illicit drugs in various countries across the globe.

Drug Abuse Testing Market

The top five drug classes are amphetamines, opiates, alcohol, cocaine, and cannabis, accounting for an 80.8% market share in the global drug abuse testing (DAT) market. The urine sample is highly preferred for initial screening and confirmation. However, the adoption of saliva samples for screening is expected to create lucrative opportunities over the future years due to the manipulation or adulteration of urine samples with synthetic urine by drug abusers. Forensic laboratories prefer hair samples, which may be given for substances abused 90 days back. However, if the person has no hair or short hair, forensic laboratories prefer a nail test. For the majority of urine and saliva samples, immunoassay and onsite testing are highly preferred for initial screening, and positive samples should be confirmed by mass spectrometry.

Drug Abuse Testing (DAT) Market Key Developments:
  • In Sept 2019, A new distribution contract was signed by Psychemedics Corporation with Toxicologia Pardini Ltda. and Sanso Holding S.A. in Brazil. Toxicologia Pardini and Sanso was chosen as the Brazilian distributor for Psychemedics' hair drug testing services under the terms of the new deal.

Drug Abuse Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

3.9%

Largest Market

North-America

Fastest Growing Market

North America
Drug Abuse Testing (DAT) Market Dynamics

A growing number of drug users across the globe is responsible for the growth of the drug abuse testing market. The increase in the consumption of alcohol and other illicit drugs such as cannabis, cocaine, heroin, and opiates is a major factor in the growth of the global drug abuse testing market over the forecast years. For instance, according to UNODC 2021, approximately 296 Million people had used drugs per year. However, the number of drugs is gradually increasing due to the rapid growth in population, and unemployment is contributing to drug abuse testing growth around the world. Cannabis is a highly used illicit drug, with an estimated approximately 219 Million people per year around the world. In 2021, approximately 36 Million used amphetamines, 22 million used cocaine, and 20 million used ecstasy.  In addition, according to UNODC 2021 data, opioids contribute to drug-related harm that includes fatal overdoses. Around 60 million people engaged in non-medical opioid use in 2021, and 31.5 million used mainly opiates (heroin).

Drug Abuse Testing Market Segmentation

By Technology
  • Immunoassay
  • On-site Testing
  • Mass Spectrometry
  • Others
By Sample Type
  • Urine
  • Saliva
  • Blood
  • Hair
  • Others
By Geography
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

Every year, approximately 222 Million drug abuse tests take place across the globe.

Abbott Laboratories, Danaher Corporation (Beckman Coulter), LabCorp, Dragerwerk AG & Co. KGaA, Quest Diagnostics Inc.

North America is the fastest-growing region for Drug Abuse Testing Market

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1.Executive Summary
2.Global Drug Abuse Testing Market Introduction 
2.1.Global Drug Abuse Testing Market  - Taxonomy
2.2.Global Drug Abuse Testing Market  - Definitions
2.2.1.Technology
2.2.2.Sample Type
2.2.3.Region
3.Global Drug Abuse Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Drug Abuse Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Drug Abuse Testing Market  By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Immunoassay
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. On-site Testing
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Mass Spectrometry
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Drug Abuse Testing Market  By Sample Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Urine
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Saliva
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Blood
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Hair
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Drug Abuse Testing Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Drug Abuse Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Immunoassay
8.1.2.On-site Testing
8.1.3.Mass Spectrometry
8.1.4.Others
8.2.  Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Urine
8.2.2.Saliva
8.2.3.Blood
8.2.4.Hair
8.2.5.Others
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Drug Abuse Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Immunoassay
9.1.2.On-site Testing
9.1.3.Mass Spectrometry
9.1.4.Others
9.2.  Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Urine
9.2.2.Saliva
9.2.3.Blood
9.2.4.Hair
9.2.5.Others
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Drug Abuse Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Immunoassay
10.1.2.On-site Testing
10.1.3.Mass Spectrometry
10.1.4.Others
10.2.  Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Urine
10.2.2.Saliva
10.2.3.Blood
10.2.4.Hair
10.2.5.Others
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Drug Abuse Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Immunoassay
11.1.2.On-site Testing
11.1.3.Mass Spectrometry
11.1.4.Others
11.2.  Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Urine
11.2.2.Saliva
11.2.3.Blood
11.2.4.Hair
11.2.5.Others
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Drug Abuse Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Immunoassay
12.1.2.On-site Testing
12.1.3.Mass Spectrometry
12.1.4.Others
12.2.  Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Urine
12.2.2.Saliva
12.2.3.Blood
12.2.4.Hair
12.2.5.Others
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Abbott Laboratories
13.2.2.Danaher Corporation (Beckman Coulter)
13.2.3.LabCorp
13.2.4.Dragerwerk AG & Co. KGaA
13.2.5.Quest Diagnostics Inc.
13.2.6.Randox Testing Services
13.2.7.United States Drug Testing Laboratories Inc. (USDTL)
13.2.8.Thermo Fisher Scientific Inc.
13.2.9.Siemens Healthineers AG
13.2.10.Hoffmann-La Roche Ltd
14. Research Methodology 
15. Appendix and Abbreviations 
  • Accuquik Test Kits
  • Advin Biotech
  • Alere, Inc. (Abbott)
  • Alfa Scientific Designs, Inc.
  • Andatech
  • ARK Diagnostics
  • Biopanda Reagents
  • Beckman Coulter
  • BTNX, Inc.
  • Corolina Liquid Chemistries
  • Chromsystems, Inc.
  • Co-Innovation Biotech Co., Ltd.
  • Confirm Biosciences
  • Diagnostic Automation/Cortez Diagnostics Inc.
  • Diasystems Scandinevia AB
  • Germaine Laboratories, Inc.
  • Innovative Testing Solution
  • Immunostics, Inc.
  • Medacx Ltd.
  • Meridian Healthcare srl
  • Mossman Associates
  • Neogen Corporation
  • Orasure Technologies, Inc.
  • Pharmatech, Inc.
  • Premier Biotech
  • Prospectol
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

Adjacent Markets